1. Brenda Crowe works as a Statistical Research Advisor at Eli Lilly and Company (IN, USA). She obtained a PhD in statistics from the University of Toronto (ON, Canada) in 1997. She currently leads a Safety Analytics team that seeks to improve safety signal detection and evaluation.
2. Wei Wang works as a Statistician with the Safety Analytics team at Eli Lilly and Company. She obtained a MD from the Capital University of Medical Sciences (Beijing, China) and a MPH from the University of Hawaii (USA). She has 13 years of experience working in drug development. Her research interests include analytical methods on safety data in clinical trials, visual analytics and meta-analysis.
3. Mary E Nilsson works as a Statistician at Eli Lilly and Company. She obtained a Master’s in statistics from Iowa State University (USA) in 1989. Her experience has primarily been in Phase II–IV clinical trials. Her primary interests include safety analytics, statistical analysis planning, and collection and analysis of suicide-related events.